Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
The current price of Eli Lilly And Co in the market is Rp 20.745.935,09, with a 24-hour trading volume of Rp 22,25T. The asset's market cap is Rp 18,49P, after moving -1.84% in the last day.
Tokenized Eli Lilly And Co is trading at Rp 20.898.291,13, with a tokenized market cap of Rp 815,94B and a 24-hour trading volume of Rp 33B. The tokenized asset has moved -1.07% in the past 24 hours.